Efficacy and Safety of Aripiprazole in Alcohol Dependence

Dopaminergic agonists and antagonists have both been examined for the treatment of substance abuse with contrasting results. To the best of our knowledge dopamine receptor partial agonists have not been investigated in alcohol use disorders. Thirteen detoxified alcohol-dependent subjects were treated with flexible doses of aripiprazole for 16 weeks. Six patients maintained an alcohol free condition for all the study period. All the subjects experienced a reduction of craving in both OCDS (p < .05) and VAS (p < .05), and a decrease of the SCL-90 General Severity Index (GSI) (p < .05). The data of this pilot clinical study, suggest a possible role for this drug in the treatment of individuals with alcohol problems.

[1]  C. Naranjo,et al.  Long-acting injectable bromocriptine does not reduce relapse in alcoholics. , 1997, Addiction.

[2]  A. Dobson,et al.  Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. , 1981, Journal of chronic diseases.

[3]  S. Stahl.  Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action. , 2001, The Journal of clinical psychiatry.

[4]  Henry F. Beresford,et al.  Aripiprazole in Schizophrenia With Cocaine Dependence: A Pilot Study , 2005, Journal of clinical psychopharmacology.

[5]  M. Christensen,et al.  Patients with Schizophrenia Treated with Aripiprazole, a Multicentre Naturalistic Study , 2022 .

[6]  C. Naranjo,et al.  Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). , 1989, British journal of addiction.

[7]  L. Covi,et al.  SCL-90: an outpatient psychiatric rating scale--preliminary report. , 1973, Psychopharmacology bulletin.

[8]  V. Borg.  Bromocriptine in the prevention of alcohol abuse , 1983, Acta psychiatrica Scandinavica.

[9]  G. Dunn,et al.  Tiapride in the Long-term Management of Alcoholics of Anxious or Depressive Temperament , 1987, British Journal of Psychiatry.

[10]  W. Stoops,et al.  A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine. , 2006, Drug and alcohol dependence.

[11]  W. van den Brink,et al.  A three-pathway psychobiological model of craving for alcohol. , 1999, Alcohol and alcoholism.

[12]  K. Ramskogler,et al.  Dopamine and alcohol relapse: D1 and D2 antagonists increase relapse rates in animal studies and in clinical trials. , 2001, Journal of biomedical science.

[13]  M. Di Giannantonio,et al.  The Italian version of the Obsessive-Compulsive Drinking Scale: validation, comparison with the other versions, and difference between type 1- and type 2-like alcoholics. , 2004, Drug and alcohol dependence.

[14]  P. Hyytiä,et al.  Effects of aripiprazole on alcohol intake in an animal model of high-alcohol drinking. , 2006, Alcohol and alcoholism.

[15]  B. Hoebel,et al.  A high-fat meal or injection of lipids stimulates ethanol intake. , 2004, Alcohol.

[16]  F. Petty,et al.  Aripiprazole Reduces Alcohol Use , 2005, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[17]  M. Dongier,et al.  Bromocriptine in the treatment of alcohol dependence. , 1991, Alcoholism, clinical and experimental research.